Replies to post #19464 on US Stem Cell Inc (USRM)

[skichic]

Great post Hippo, I Stickied it!

[BluSkies]

Solid DD my friend!! No wonder why they are buying up so much.

[Work Harder]

WOW

Splains the beat down

Nice work Bro, makes that figure someone passed to us very real but should be higher.

@ an os of 100 or 120 mil is there based on the O's price

The shakes will be much higher & it's going to be interesting as to who can hold it much higher b/c when it happens.

You are either in or out

:}

[zeekhoe]

sick DD, Hippo, I'm looking for a position tmrw.

[BluSkies]

HH, amazing due diligence and comparison of other stem cell biotech companies. Coming across one of your comparisons, I noticed recently as of late last year Ocata Therapeutics (OCAT) was Acquired by Astellas for $379M, so it is surprising or almost unbelievable that USRM is currently valued at the market cap of $250k? I'd like to explore this more with you. In the meantime, do you know what clinical Phase Ocata was at?

http://www.genengnews.com/gen-news-highlights/astellas-to-acquire-ocata-therapeutics-for-379m/81251957

[nonewname1]

Why doesn't it matter how much cash they have? Don't trials cost money?